• Karachi, Pakistan

The Searle Company Limited - SEARL

Company Details

Sector PHARMACEUTICALS
Address One IBL Centre 2nd Floor Plot # 1 Block 7 & 8 D.M.C.H.S Tipu Sultan Road Off Shahrah-e-Faisal Karachi
Auditor A. F. Ferguson & Co. Chartered Accountants
Registrar CDC Share Registrar Services Limited, CDC House, 99-B , Block B S.M.C.H.S Main Shahrah-e-Faisal, Karachi
Website www.searlecompany.com
Fiscal Year June
Details

Details

The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993@ the Company was converted into a public limited company under the repealed Companies Ordinance@ 1984 (now Companies Act@ 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company@ which holds 56.32% shareholding in the Company.

Company Announcements

Date/Time Announcement
30/10/2023   09:53:32 EPS = 0.31
FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 30/09/2023
(CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 341.352
(CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 137.958
30/10/2023   09:52:53 EPS = 0.83
FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 30/09/2023
(UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 462.950
(UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 324.635
28/09/2023   15:22:31 FINANCIAL RESULT FOR THE YEAR ENDED 30/06/2023
(CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,144.124
(CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 413.053
EPS = 0.80
28/09/2023   15:21:51 EPS = 0.77
ANNUAL GENERAL MEETING HELD ON 27/10/2023
BOOK CLOSURE FROM 21/10/2023
FINANCIAL RESULT FOR THE YEAR ENDED 30/06/2023
BOOK CLOSURE TO 27/10/2023
(UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 409.835
(UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 302.137
08/08/2023   14:36:54 FOR THE YEAR ENDED 30/06/2023
BOOK CLOSURE FROM 21/08/2023
BOOK CLOSURE TO 25/08/2023
RIGHT ISSUE = 31.13 AT A PREMIUM OF Rs.25/= PER SHARE

Last 30 Days Performance